Ranger Investment Management’s Phibro Animal Health PAHC Stock Holding History

Ranger Investment Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.18M	Buy	292,410 +13,935	+5%	+$588K	0.58%	63
2026 Q1	$15.4M	Sell	278,475 -950	-0.3%	-$45.2K	1.11%	44
2025 Q4	$10.4M	Sell	279,425 -20,485	-7%	-$832K	0.72%	54
2025 Q3	$12.1M	Sell	299,910 -58,060	-16%	-$1.92M	0.85%	50
2025 Q2	$9.14M	Buy	357,970 +179,975	+101%	+$3.92M	0.64%	54
2025 Q1	$3.8M	Buy	+177,995	New	+$3.98M	0.27%	70

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ranger Investment Management's PAHC Position: Q2 2026 in Review

Ranger Investment Management increased its Phibro Animal Health (PAHC) stake by 5% in Q2 2026, buying an estimated $588K and bringing the position to 292,410 shares worth $9.18M. The position accounts for 0.58% of the portfolio, ranked #63.

Ranger Investment Management first reported a position in PAHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.4M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Ranger Investment Management held 292,410 shares of Phibro Animal Health worth $9.18M as of Q2 2026.
Ranger Investment Management bought 13,935 Phibro Animal Health shares in Q2 2026, an estimated $588K.
Phibro Animal Health made up 0.58% of Ranger Investment Management's portfolio in Q2 2026, its #63 holding.
Ranger Investment Management first reported a position in Phibro Animal Health in Q1 2025 and has held it in 6 quarters since.
Ranger Investment Management's Phibro Animal Health position peaked at $15.4M in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Ranger Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.